IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$1.03
52W Range
$0.48 - $1.66
50D Avg
$1.09
200D Avg
$0.99
Market Cap
$56.00M
Avg Vol (3M)
$263.94K
Beta
2.59
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
ICCM Performance
Peer Comparison
| Ticker | Company |
|---|---|
| SINT | Sintx Technologies, Inc. |
| TMCI | Treace Medical Concepts, Inc. |
| ESTA | Establishment Labs Holdings Inc. |
| KIDS | OrthoPediatrics Corp. |
| CNMD | CONMED Corporation |
| BWAY | BrainsWay Ltd. |
| CLPT | ClearPoint Neuro, Inc. |
| SGHT | Sight Sciences, Inc. |
| NPCE | NeuroPace, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| TELA | TELA Bio, Inc. |
| TNON | Tenon Medical, Inc. |
| CTSO | Cytosorbents Corporation |
| SRDX | Surmodics, Inc. |
| ITGR | Integer Holdings Corporation |